Press Releases, Publications, and Media Coverage
Fyodor Biotechnologies Inc., a Baltimore-based diagnostic and biopharmaceutical company, announced today that the National Science Foundation has awarded the company a Small Business Innovation Research (SBIR) Phase 2 grant. The $476,000 funding will support Fyodor’s effort to develop and validate a broad-based non-invasive, single-step Urine Malaria Test (UMT Broad) for the clinical diagnosis of both [...]
SNNLive spoke with Anne Derrick VP, Business Development & Operations of Fyodor Biotechnologies, Inc. at the University of Maryland BioPark in Baltimore, MD. Watch the video below.
Fyodor Biotechnologies, a Baltimore-based diagnostic and biopharmaceutical company, announced today that the National Science Foundation has awarded the company a Small Business Innovation Research (SBIR) Phase I grant. With the $150,000 funding, Fyodor plans to develop a novel recombinant antibody to be used in a urine-based test for the point-of-need detection of Leptospirosis. Leptospirosis is [...]
Fyodor Biotechnologies Inc. announced today that it has expanded its office and laboratory space at the University of Maryland BioPark in Baltimore, moving from the BioPark’s BioInnovation Center (BIC) at 801 West Baltimore Street to the expanded BioInnovation Center across the street at 800 West Baltimore Street. The move is prompted by Fyodor’s advancing research [...]
Fyodor Biotechnologies, a Baltimore-based diagnostic and biopharmaceutical company, announced today that the National Science Foundation has awarded the company a Small Business Innovation Research (SBIR) Phase I grant. With the $150,000 funding, Fyodor plans to further progress the development of its innovative Urine Malaria Test (UMT) technology. “We are pleased to receive this award from the [...]
Fyodor Biotechnologies’ Chairman and CEO, Dr Eddy Agbo, was invited to participate in a panel at the 13th Annual Africa Business Conference sponsored by the Africa Business Club at the Harvard Business School February 18-20, 2011. The panel entitled “Africa’s Pharmaceutical Dilemma: The Opportunity for Private Entrepreneurs” provided a forum for interactive discussion on potential [...]
Governor Martin O’Malley announced today that State grants are available in Fiscal Year 2011 through the Maryland Biotechnology Center to assist in commercializing promising research, encouraging bio companies to collaborate with academic institutions and expanding biotechnology resources. The Governor also announced that seven Maryland bio companies and universities received $1.3 million in FY 2010 grants, [...]
Fyodor Biotechnologies announced today that Eddy C. Agbo, DVM, PhD, Chairman & CEO of Fyodor Biotechnologies Corporation, has been invited to moderate a session at the 2010 Annual Meeting of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas, Inc. (NAPPSA) to be held at The Westin Central Park Hotel in Dallas, Texas [...]
Professor Bartho Okolo, Vice Chancellor, led a team from the University of Nigeria Nsukka, to the University of Maryland School of Medicine, Baltimore and The Johns Hopkins University Baltimore, July 21-22, 2010, to explore potential areas of inter-institutional collaboration. The visit was facilitated and hosted by Eddy C. Agbo, DVM, PhD, Chairman & CEO of [...]
Eddy C. Agbo, DVM, PhD, Chairman & CEO of Fyodor Biotechnologies Corporation, has been invited to speak at the 2010 US-Africa Private Sector Health Conference. The conference, to be held at the Grand Hyatt Hotel in Washington DC from October 4-6, 2010, is the premier forum to address the role of the US and African private [...]